Growth Of The Yellow Fever Vaccine Market Due To Increasing International Travel: Key Factor Driving The Growth In The Yellow Fever Vaccine Market

The Yellow Fever Vaccine Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].

What Is the Expected Yellow Fever Vaccine Market Size During the Forecast Period?
The yellow fever vaccine market has grown significantly in recent years. It will rise from $4.54 billion in 2024 to $4.79 billion in 2025, reflecting a compound annual growth rate (CAGR) of 5.4%. The growth in the historic period can be attributed to global immunization campaigns, the implementation of international health regulations, mass vaccination initiatives, and advancements in vaccine production technologies.

The yellow fever vaccine market is expected to see solid growth, reaching $5.84 billion by 2029 at a CAGR of 5.1%. This growth is driven by increased partnerships, integration with routine vaccination, surveillance efforts, private sector involvement, and the use of digital technologies for tracking. Trends include vaccine diversification, pandemic preparedness, regulatory changes, TH*Care improvements, and consumer education.

Purchase the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=17297

What Are the High-Growth Segments in the Yellow Fever Vaccine Market?
The yellow fever vaccine market covered in this report is segmented -

1) By Product: Powder, Liquid
2) By Treatment Type: Pain Management Drugs, Oral Rehydration
3) By Application: Routine Immunization, Travelers, Other Applications
4) By End-User: Hospitals, Diagnostic Centers, Point Of Care Centers, Other End Users

Subsegments:
1) By Powder: Lyophilized Powder For Reconstitution, Freeze-Dried Powder For Reconstitution
2) By Liquid: Ready-To-Use Liquid Vaccine, Liquid Vaccine In Pre-Filled Syringes

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=17297&type=smp

What Key Drivers Are Expected to Influence Future Yellow Fever Vaccine Market Growth?
The yellow fever vaccine market is likely to grow due to an increase in international travel. The growing trend of global travel, driven by improved connectivity and post-pandemic recovery, necessitates vaccination against yellow fever for travel to endemic regions. In 2023, international tourist arrivals reached 1.286 billion, showing a significant increase from 2022.

Which Companies Hold the Largest Share Across Different Yellow Fever Vaccine Market Segments?
Major companies operating in the yellow fever vaccine market are Merck and Co Inc., Sanofi S.A., GSK plc, Takeda Pharmaceutical Company, Lonza Group Ag, WuXi Biologics, Novavax Inc., Beijing Tiantan Biological, Bavarian Nordic A/S, Valneva SE, Biological E. Limited, Bio-Manguinhos, Instituto Butantan, Bio Farma, Panacea Biotec, Biovac, Institut Pasteur de Dakar, Ology Bioservices, Gavi, Wuhan Institute of Biological Products, PnuVax Incorporated, iBio Inc.

What Are the Latest Developing Trends in the Yellow Fever Vaccine Market?
Companies in the yellow fever vaccine market are developing next-generation vaccines, like the T-cell adaptive booster vaccine, to address increasing global demand. These vaccines enhance the immune system's memory T-cell response, providing longer-lasting immunity. For example, in April 2022, Emergex Vaccines Holding Limited, a UK-based company, partnered with ATCC, a US-based non-profit, to develop CD8+ T-cell adaptive vaccines for yellow fever. These vaccines aim to stimulate strong T-cell responses and provide more robust and lasting immunity compared to traditional vaccines.

Get the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/report/yellow-fever-vaccine-global-market-report

What Are the Emerging Geographies for The Yellow Fever Vaccine Market Growth?
North America was the largest region in the yellow fever vaccine market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the yellow fever vaccine market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Frequently Asked Questions:
1. What Is the Market Size and Growth Rate of the Yellow Fever Vaccine Market?
2. What is the CAGR expected in the Yellow Fever Vaccine Market?
3. What Are the Key Innovations Transforming the Yellow Fever Vaccine Industry?
4. Which Region Is Leading the Yellow Fever Vaccine Market?

Why This Report Matters:

Competitive overview: This report analyzes the competitive landscape of the 3D imaging software market, evaluating key players on market share, revenue, and growth factors.

Informed Decisions: Understand key strategies related to products, segmentation, and industry trends.

Efficient Research: Quickly identify market growth, leading players, and major segments.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.